388 related articles for article (PubMed ID: 19836445)
1. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a recombinant androgen receptor binding assay: initial steps towards validation.
Freyberger A; Weimer M; Tran HS; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):2-8. PubMed ID: 19833195
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
Freyberger A; Wilson V; Weimer M; Tan S; Tran HS; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):50-9. PubMed ID: 20074635
[TBL] [Abstract][Full Text] [Related]
4. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
[TBL] [Abstract][Full Text] [Related]
5. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
[TBL] [Abstract][Full Text] [Related]
6. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
Freyberger A; Scholz G
ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
[TBL] [Abstract][Full Text] [Related]
7. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR
Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883
[TBL] [Abstract][Full Text] [Related]
9. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies.
Owens W; Gray LE; Zeiger E; Walker M; Yamasaki K; Ashby J; Jacob E
Environ Health Perspect; 2007 May; 115(5):671-8. PubMed ID: 17520051
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
11. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells.
Maness SC; McDonnell DP; Gaido KW
Toxicol Appl Pharmacol; 1998 Jul; 151(1):135-42. PubMed ID: 9705896
[TBL] [Abstract][Full Text] [Related]
13. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
Guth SE; Böhm S; Mussler BH; Eisenbrand G
Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
[TBL] [Abstract][Full Text] [Related]
14. Cell viability and PSA secretion assays in LNCaP cells: a tiered in vitro approach to screen chemicals with a prostate-mediated effect on male reproduction within the ReProTect project.
Lorenzetti S; Marcoccia D; Narciso L; Mantovani A
Reprod Toxicol; 2010 Aug; 30(1):25-35. PubMed ID: 20363314
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
16. The application of reporter gene assays for the detection of endocrine disruptors in sport supplements.
Plotan M; Elliott CT; Scippo ML; Muller M; Antignac JP; Malone E; Bovee TF; Mitchell S; Connolly L
Anal Chim Acta; 2011 Aug; 700(1-2):34-40. PubMed ID: 21742114
[TBL] [Abstract][Full Text] [Related]
17. Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
van der Burg B; Winter R; Weimer M; Berckmans P; Suzuki G; Gijsbers L; Jonas A; van der Linden S; Witters H; Aarts J; Legler J; Kopp-Schneider A; Bremer S
Reprod Toxicol; 2010 Aug; 30(1):73-80. PubMed ID: 20435135
[TBL] [Abstract][Full Text] [Related]
18. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
19. Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development.
Wilson VS; Blystone CR; Hotchkiss AK; Rider CV; Gray LE
Int J Androl; 2008 Apr; 31(2):178-87. PubMed ID: 18315717
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
